BBH ETF holdings (NASDAQ) | MetaTrader

Open full chart

Overview All holdings Heatmap

Top holdings Market Value Shares Weight %

AMGN Amgen Inc 60.32 M 166.57 K 15.25%

GILD Gilead Sciences Inc 50.58 M 400.34 K 12.79%

VRTX Vertex Pharmaceuticals Inc 36.01 M 72.48 K 9.10%

REGN Regeneron Pharmaceuticals Inc 24.56 M 39.39 K 6.21%

RVMD Revolution Medicines Inc 20.86 M 111.38 K 5.27%

ARGX Argenx SE 19.67 M 21.20 K 4.97%

NTRA Natera Inc 19.46 M 71.68 K 4.92%

IQV IQVIA Holdings Inc 17.03 M 88.16 K 4.31%

ALNY Alnylam Pharmaceuticals Inc 15.16 M 50.36 K 3.83%

BIIB Biogen Inc 14.35 M 66.39 K 3.63%

MRNA Moderna Inc 13.30 M 189.95 K 3.36%

ILMN Illumina Inc 12.54 M 71.33 K 3.17%

UTHR United Therapeutics Corp 11.18 M 20.63 K 2.83%

ONC BeOne Medicines Ltd 11.11 M 39.00 K 2.81%

INSM Insmed Inc 10.56 M 99.05 K 2.67%

INCY Incyte Corp 9.86 M 86.95 K 2.49%

NBIX Neurocrine Biosciences Inc 8.24 M 48.86 K 2.08%

BNTX BioNTech SE 7.68 M 82.54 K 1.94%

ICLR ICON PLC 7.52 M 43.32 K 1.90%

TECH Bio-Techne Corp 6.10 M 86.31 K 1.54%

1
2

News

Market Concentration: Building For More Than One Outcome

Equity Outlook: AI, Higher Rates Raise The Bar For Diversification

Where Healthcare Innovation Meets Investment Opportunity

David Rubenstein Of The Carlyle Group On The Business Of Sports, Investing And Leadership

Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate

5 Undervalued Oncology Stocks Wall Street Is Overlooking (NASDAQ:IBB)

'Anthropic quietly sets up biology lab as it ramps AI drug program' - Reuters Exclusive

Should You Invest in the VanEck Biotech ETF (BBH)?

The Market May Be Telling Us We're Entering A Capital Formation Cycle

How Is Vertex Pharmaceuticals' Stock Performance Compared to Other Biotech Stocks?

Where Is Growth?

The Investor Mentality